Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

NCT01031901 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Tuberous Sclerosis
Neurofibromatoses
Angiofibroma
Neurofibroma

Interventions

DRUG: Skincerity
DRUG: Skincerity plus sirolimus/rapamycin
DRUG: Skinercity plus sirolimus/rapamycin

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

[object Object]